Updates are available Correction dated 2022-02-15
Click to view Correction: https://doi.org/10.1007/s10741-022-10222-0
-
Authors
Yehya, Amin https://orcid.org/0000-0001-5947-4778
Davis, Jonathan D.
Sauer, Andrew J.
Ibrahim, Nasrien E.
- License Information
-
More Information
Article History
Accepted: 10 January 2022
First Online: 26 January 2022
Change Date: 15 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10741-022-10222-0
Declarations
:
: Dr. Yehya received honoraria from Merck, Zoll, Akcea therapeutics and CareDx. Dr. Davis served on an advisory board for Novartis. Dr. Sauer serves as a consultant and has received research support funding from Abbott, Boston-Scientific, Impulse Dynamics, Edwards, Biotronik and Medtronic. Dr. Ibrahim has received honoraria from Cytokinetics, Medtronic, Novartis and Roche and is a consultant for Cytokinetics.
